HK1082958A1 - Tumor-lysing virus growing selectively in tumor cells - Google Patents

Tumor-lysing virus growing selectively in tumor cells

Info

Publication number
HK1082958A1
HK1082958A1 HK06102821.5A HK06102821A HK1082958A1 HK 1082958 A1 HK1082958 A1 HK 1082958A1 HK 06102821 A HK06102821 A HK 06102821A HK 1082958 A1 HK1082958 A1 HK 1082958A1
Authority
HK
Hong Kong
Prior art keywords
tumor
tumor cells
virus growing
growing selectively
lysing virus
Prior art date
Application number
HK06102821.5A
Other languages
English (en)
Inventor
Toshiyoshi Fujiwara
Noriaki Tanaka
Satoru Kyo
Yoshiko Shirakiya
Takeshi Kawashima
Original Assignee
Kansai Tech Licensing Org Co
Oncolys Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansai Tech Licensing Org Co, Oncolys Biopharma Inc filed Critical Kansai Tech Licensing Org Co
Publication of HK1082958A1 publication Critical patent/HK1082958A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK06102821.5A 2002-07-08 2006-03-03 Tumor-lysing virus growing selectively in tumor cells HK1082958A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002198941A JP3867968B2 (ja) 2002-07-08 2002-07-08 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス
PCT/JP2003/008573 WO2004005511A1 (ja) 2002-07-08 2003-07-07 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス

Publications (1)

Publication Number Publication Date
HK1082958A1 true HK1082958A1 (en) 2006-06-23

Family

ID=30112441

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06102821.5A HK1082958A1 (en) 2002-07-08 2006-03-03 Tumor-lysing virus growing selectively in tumor cells

Country Status (15)

Country Link
US (1) US20060239967A1 (xx)
EP (1) EP1553178B1 (xx)
JP (1) JP3867968B2 (xx)
KR (2) KR100947194B1 (xx)
CN (1) CN100430476C (xx)
AU (1) AU2003281310B2 (xx)
CA (1) CA2491907C (xx)
DK (1) DK1553178T3 (xx)
ES (1) ES2455127T3 (xx)
HK (1) HK1082958A1 (xx)
NZ (1) NZ537631A (xx)
PL (1) PL374644A1 (xx)
PT (1) PT1553178E (xx)
WO (1) WO2004005511A1 (xx)
ZA (1) ZA200500047B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
EP1745801A1 (en) * 2004-05-13 2007-01-24 Daiichi Pharmaceutical Co., Ltd. Method of inhibiting telomerase activity and inhibitor
CN100361710C (zh) * 2004-06-07 2008-01-16 成都康弘生物科技有限公司 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用
US7943373B2 (en) * 2004-09-29 2011-05-17 Oncolys Biopharma, Inc. Telomelysin/GFP-expressing recombinant virus
US20100150884A1 (en) * 2005-02-10 2010-06-17 Oncolys Biopharma Inc. Anticancer Agent to Be Combined with Telomelysin
JP5069871B2 (ja) * 2006-05-30 2012-11-07 シスメックス株式会社 新規な癌細胞検出試料調製用キット及びそれを用いた癌細胞検出用キット
WO2008065726A1 (fr) * 2006-11-29 2008-06-05 Oncolys Biopharma Inc. Agent contenant du télomelysin destiné à rompre la tolérance anti-tumorale
WO2008136213A1 (ja) * 2007-04-27 2008-11-13 Oncolys Biopharma Inc. 放射線増感増強剤
US20090181931A1 (en) * 2008-01-16 2009-07-16 Oncolys Biopharma, Inc. Antiviral activity of cidofovir against oncolytic viruses
US20110250588A1 (en) 2008-12-18 2011-10-13 Sysmex Corporation Method for detecting cancer cells in blood sample
US9645154B2 (en) 2010-12-24 2017-05-09 Arkray, Inc. Method for detecting cancer cell
CN106591368A (zh) * 2016-10-12 2017-04-26 郑州大学 携带il‑15r/il‑15融合基因的b亚群腺病毒11载体及其构建和用途
AU2018349889B2 (en) 2017-10-10 2024-02-08 National University Corporation Tottori University Enhancer for T-cells or B-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in T-cells or B-cells
US20220249127A1 (en) * 2019-05-14 2022-08-11 Oncolys Biopharma Inc. Method for administering oncolytic virus to tumor tissue, and device for administration
IL292542A (en) 2019-10-28 2022-06-01 Noile Immune Biotech Inc A drug for the treatment of cancer, a mixture of drugs, a medicinal preparation, a cell that responds to an immune campaign, a carrier for the transfer of nucleic acids and a product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1275299A (en) * 1997-10-23 1999-05-10 Uab Research Foundation Human papillomavirus vectors for the episomal transduction of host cells and method of making same
AU761567B2 (en) 1999-02-04 2003-06-05 Geron Corporation Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
US6692736B2 (en) * 2000-03-24 2004-02-17 Cell Genesys, Inc. Cell-specific adenovirus vectors comprising an internal ribosome entry site
WO2001073093A2 (en) 2000-03-24 2001-10-04 Cell Genesys, Inc. Cell-specific adenovirus vectors comprising an internal ribosome entry site
IL152420A0 (en) * 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
CN1177042C (zh) * 2001-04-12 2004-11-24 上海华康生物技术有限公司 共表达人p53基因和人细胞因子基因的重组腺病毒及其制法和用途
CN1195056C (zh) * 2001-07-12 2005-03-30 钱其军 一种在肿瘤细胞中特异性增殖及高效表达抗癌基因的重组病毒及其构建方法

Also Published As

Publication number Publication date
NZ537631A (en) 2007-05-31
EP1553178B1 (en) 2014-03-05
ES2455127T3 (es) 2014-04-14
EP1553178A1 (en) 2005-07-13
WO2004005511A1 (ja) 2004-01-15
EP1553178A4 (en) 2006-03-29
DK1553178T3 (da) 2014-05-19
CN1665927A (zh) 2005-09-07
JP2004033186A (ja) 2004-02-05
CN100430476C (zh) 2008-11-05
KR100947194B1 (ko) 2010-03-11
PL374644A1 (en) 2005-10-31
ZA200500047B (en) 2006-05-31
CA2491907C (en) 2013-03-19
KR20090043589A (ko) 2009-05-06
AU2003281310A1 (en) 2004-01-23
JP3867968B2 (ja) 2007-01-17
AU2003281310B2 (en) 2008-02-21
CA2491907A1 (en) 2004-01-15
US20060239967A1 (en) 2006-10-26
KR20050075867A (ko) 2005-07-22
PT1553178E (pt) 2014-06-12

Similar Documents

Publication Publication Date Title
HK1082958A1 (en) Tumor-lysing virus growing selectively in tumor cells
HK1181815A1 (zh) 基因組被修飾的細胞
EP1644135A4 (en) IMPROVED SOLAR CELLS
EP1619728A4 (en) SOLAR CELL
IL214546A0 (en) Pilot signals for use in multi-sector cells
GB0206461D0 (en) Improvements in vaccination
AU2003290432A8 (en) T cell activating gene
AU2003220387A8 (en) Gene amplification in cancer
GB0315846D0 (en) Solar cells and encapsulation thereof
EP1521328A4 (en) SOLAR CELL
GB0206357D0 (en) Cells
ZA200506732B (en) Cell culture
GB2422843B (en) Cell culture base
GB2403093B (en) Improvements in loudspeakers
AU2003270335A8 (en) Pond rake
EP1501722A4 (en) IMPROVEMENTS IN THE BEAUPRES
GB0302258D0 (en) Improvements in and relating to cell growth
ZA200501352B (en) Cell culture surface
AU2003249912A1 (en) Peptides for inducing apoptosis in tumor cells
AU2003230671A8 (en) Improvements in electrochemistry technical field
GB0325085D0 (en) Improvements in cell growth
GB0328943D0 (en) Differentiated cells
GB0206309D0 (en) Isolated cells
GB0219106D0 (en) Improvements in loudspeakers
PL376397A1 (en) Transplantable cell

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230706